Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.
Kevin H.M. Kuo(University Health Network), Hans A. Messner(University of Toronto), Jeffrey H. Lipton(Princess Margaret Cancer Centre), Mark D. Minden(University Health Network), Joseph Brandwein(Goethe University Frankfurt), Aaron D. Schimmer(University of Toronto), Graham D. Sher(Unknown), Armand Keating(University Health Network), Karen Yee(University Health Network), Michael Crump(University of Toronto), Vikas Gupta(Indian Institute of Technology Kanpur), Jeannie Callum(Sunnybrook Health Science Centre), David Sutton(University Health Network), Andre C. Schuh(University of Toronto), John E. Curtis(London Health Sciences Centre), Dominic Pantalony(University Health Network)
Cited by 10
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737